Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host disease.

Front Immunol · 2026 · PMC13143746 · PMID 42099615

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

10%, respectively), although these differences did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

As expected, RUX-ECP was associated with RUX-specific toxicities, notably grade 3/4 anemia, and showed a trend towards CMV reactivation ( 22 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.